Research Corporation Technologies
VC · Tucson (United States)
Sign up free to access full profile and submit your pitch.
About
Research Corporation Technologies is a venture capital firm specializing in start up and early-stage companies. It is a technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production. With medical devices, it invests in preclinical and early clinical candidate interventional medical devices, preclinical and early clinical candidate temporary or permanent indwelling devices, devices that address unmet medical needs and offer significant clinical benefits over existing medical practices, devices that reduce the invasiveness of current surgical and medical procedures, and cost-effective improvements in clinical care for significant patient populations. Within preclinical and clinical-stage drugs, diagnostics, and devices, the firm focuses on cancer, pain and metabolic diseases; cardiovascular diseases; back-of-the-eye and immune disorders; and infectious diseases and diagnostics. Within cancer, it focuses on anticancer agents, agents to treat cancer-related morbidities, and cancer diagnostics. Within cardiovascular diseases, the firm focuses on preclinical and early clinical candidate compounds to treat or prevent cardiomyopathies, hypertension, atherosclerosis, reperfusion-related conditions, myocardial and cerebral, infarction, preclinical, and early clinical devices for treating and preventing cardiac, peripheral and cerebral vascular disease, cardiac valve disorders, cardiac conduction disorders, and conditions associated with heart failure. Within ophthalmology, the firm focuses on preclinical and early clinical candidates targeted to treat retinal degenerative diseases of the back of the eye and novel drugs or ophthalmologic formulations with solid preclinical or clinical data. While investing in inflammation, it focuses on preclinical and early clinical therapeutic candidates, new chemical entities or novel biological and novel reformulations of approved drugs. While investing in anti-infective therapeutics, the firm focuses on preclinical and early clinical therapeutic candidates, new chemical entities or novel biological and novel reformulations of approved drugs for targeted therapeutics. It also invests in autoimmune disorders, cancer and supportive care, cardiovascular diseases, dermatologic disorders, oncology, central nervous system disorders, diabetes and metabolic disease, gastrointestinal disorders, inflammation, neurologic disorders, obesity, and ophthalmological diseases, pain, and pulmonary disorders. The firm seeks to invest in technologies developed by universities and research institutions. It invests in the West Coast region of the United States. It prefers to focus its investments on opportunities that promise patented biomedical products. Research Corporation Technologies Inc. was founded in 1987 and is based in Tucson, Arizona with additional offices in United States.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
